Zobrazeno 1 - 10
of 96
pro vyhledávání: '"James Harnett"'
Publikováno v:
Practical Laboratory Medicine, Vol 38, Iss , Pp e00349- (2024)
C-reactive protein (CRP) is an established acute-phase marker for infection, inflammation and tissue injury, used to guide clinical decision-making in primary and secondary care. This study compared the analytical performance of the quantitative micr
Externí odkaz:
https://doaj.org/article/92dee181fc2b476891d06b3fc080e0b5
Autor:
Katja Weisel, Vania Hungria, Hang Quach, Sung-Soo Yoon, Paula Rodríguez-Otero, Glenn Kroog, Arijit Sinha, Anita Boyapati, Charlotte Lyon, Karen Rodriguez Lorenc, Timothy Inocencio, James Harnett, Lei Chi, Vygngley Moore, Peter Voorhees
Publikováno v:
HemaSphere, Vol 7, p e465366a (2023)
Externí odkaz:
https://doaj.org/article/331bd93f48144d34a96f1aff164681fb
Autor:
Gandhi Laurent Damaj, Emmanuel Bachy, Qiufei MA, Christian Hampp, James Harnett, Rachel E Sobel, Jessica J Jalbert, Ruben Gw Quek, Wenhui Wei, Ning Wu, Vera Mastey, Joy Wang, Anit Bajwa, Benedikt Maissenhaelter, Chantal van Gils, Shivani Aggarwal, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Catherine Thieblemont
Publikováno v:
HemaSphere, Vol 7, p e216071d (2023)
Externí odkaz:
https://doaj.org/article/0decdad615ff4e7a96936adcd3f326a4
Autor:
Catherine Thieblemont, Qiufei MA, Christian Hampp, James Harnett, Rachel E Sobel, Jessica J Jalbert, Ruben Gw Quek, Wenhui Wei, Ning Wu, Vera Mastey, Joy Wang, Anit Bajwa, Benedikt Maissenhaelter, Chantal van Gils, Shivani Aggarwal, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Emmanuel Bachy, Gandhi Laurent Damaj
Publikováno v:
HemaSphere, Vol 7, p e6096515 (2023)
Externí odkaz:
https://doaj.org/article/42d0022639214f1e88e5587e975c120f
Autor:
Ying Li, Matthew Brendel, Ning Wu, Wenzhen Ge, Hao Zhang, Petra Rietschel, Ruben G. W. Quek, Jean-Francois Pouliot, Fei Wang, James Harnett
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Immune checkpoint inhibitors (ICIs) are standard-of-care as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC) without actionable oncogenic driver mutations. While clinical trials demonstrated benefits of ICIs over chem
Externí odkaz:
https://doaj.org/article/b6aee78bafce467e88865d8f41370075
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 1, Pp 161-168 (2020)
The CDC Advisory Committee on Immunization Practices (ACIP) recommended immunization with the recently licensed 13-valent pneumococcal conjugate vaccine (PCV13) for high-risk (immunocompromised) adults aged ≥19 years in 2012. This was in addition t
Externí odkaz:
https://doaj.org/article/3c5d5a2ac2bc4d8f8a172e75dc1a1b9b
Publikováno v:
BMC Geriatrics, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The risk of community-acquired pneumonia (CAP) increases with age and significantly impacts morbidity and mortality in the elderly population. The burden of illness and cost of preventing CAP has not been compared to other serious
Externí odkaz:
https://doaj.org/article/f46c9cbc7c754ff580aef6c7409eb692
Autor:
Daniel D Maeng, Walter F Stewart, Xiaowei Yan, Joseph A Boscarino, Jack Mardekian, James Harnett, Michael R Von Korff
Publikováno v:
Pain Research and Management, Vol 20, Iss 5, Pp 234-240 (2015)
BACKGROUND: Low back pain (LBP) is a debilitating condition that is complex to manage. One reason is that clinicians lack means to identify early on patients who are likely to become high care utilizers.
Externí odkaz:
https://doaj.org/article/fa374397b117487e9f13fbb2c09f1b44
Autor:
Ning Wu, Wenzhen Ge, Ruben GW Quek, Michelle Gleeson, Jean-Francois Pouliot, Hilary Dietz, Jessica J Jalbert, James Harnett, Scott J Antonia
Publikováno v:
Future Oncology. 18:4385-4397
Background: Trends/outcomes associated with National Comprehensive Cancer Network (NCCN)-recommended biomarker testing to guide advanced non-small-cell lung cancer (aNSCLC) treatment were assessed. Methods: Patients initiating first-line aNSCLC treat
Autor:
Ana Oaknin, Bradley J. Monk, Ignace Vergote, Andreia Cristina de Melo, Yong-Man Kim, Alla S. Lisyanskaya, Vanessa Samouëlian, Hee Seung Kim, Evgeniy A. Gotovkin, Fernanda Damian, Chih-Long Chang, Shunji Takahashi, Jingjin Li, Melissa Mathias, Matthew G. Fury, Cristina Ivanescu, Matthew Reaney, Patrick R. LaFontaine, Israel Lowy, James Harnett, Chieh-I Chen, Krishnansu S. Tewari
Publikováno v:
Scientia
Chemotherapy; Quality of life; Symptoms Quimioterapia; Calidad de vida; Síntomas Quimioteràpia; Qualitat de vida; Símptomes Background In a phase III, randomised, active-controlled study (EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9; R2810-ONC-1676; NCT0